Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study
- PMID: 21226680
- PMCID: PMC3343694
- DOI: 10.1111/j.1532-5415.2010.03201.x
Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study
Abstract
Objectives: To determine the cross-sectional and longitudinal associations between 25-hydroxyvitamin D (25(OH)D) levels and frailty status in older men.
Design: Prospective cohort study.
Setting: Six U.S. community-based centers.
Participants: One thousand six hundred six men aged 65 and older.
Measurements: 25(OH)D (liquid chromatography tandem mass spectroscopy) and frailty status (criteria similar to those used in the Cardiovascular Health Study) measured at baseline; frailty status assessment repeated an average of 4.6 years later. Frailty status was classified as robust, intermediate, or frail at baseline and robust, intermediate, frail, or dead at follow-up.
Results: After adjusting for multiple potential confounders, men with 25(OH)D levels less than 20.0 ng/mL had 1.5 times higher odds (multivariate odds ratio (MOR)=1.47, 95% confidence interval (CI)=1.07-2.02) of greater frailty status at baseline than men with 25(OH)D levels of 30.0 ng/mL or greater (referent group), whereas frailty status was similar in men with 25(OH)D levels from 20.0 to 29.9 ng/mL and those with levels of 30.0 ng/mL or greater (MOR=1.02, 95% CI=0.78-1.32). However, in 1,267 men not classified as frail at baseline, there was no association between lower baseline 25(OH)D level and odds of greater frailty status at the 4.6-year follow-up. Findings were the same when 25(OH)D was expressed in quartiles or as a continuous variable.
Conclusion: Lower levels of 25(OH)D (<20.0 ng/mL) in community-dwelling older men were independently associated with greater evidence of frailty at baseline but did not predict greater risk of greater frailty status at 4.6 years.
© 2010, Copyright the Authors. Journal compilation © 2010, The American Geriatrics Society.
Figures
Similar articles
-
Circulating 25-hydroxyvitamin D levels and frailty status in older women.J Clin Endocrinol Metab. 2010 Dec;95(12):5266-73. doi: 10.1210/jc.2010-2317. J Clin Endocrinol Metab. 2010. PMID: 21131545 Free PMC article.
-
Low vitamin D status is an independent predictor of increased frailty and all-cause mortality in older men: the Health in Men Study.J Clin Endocrinol Metab. 2013 Sep;98(9):3821-8. doi: 10.1210/jc.2013-1702. Epub 2013 Jun 20. J Clin Endocrinol Metab. 2013. PMID: 23788685
-
The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men.Age Ageing. 2013 May;42(3):352-9. doi: 10.1093/ageing/afs162. Epub 2012 Oct 30. Age Ageing. 2013. PMID: 23111338
-
Sleep disturbances and frailty status in older community-dwelling men.J Am Geriatr Soc. 2009 Nov;57(11):2085-93. doi: 10.1111/j.1532-5415.2009.02490.x. Epub 2009 Sep 28. J Am Geriatr Soc. 2009. PMID: 19793160 Free PMC article.
-
The association between 25-hydroxyvitamin D concentration, physical performance and frailty status in older adults.Eur J Nutr. 2019 Apr;58(3):1173-1181. doi: 10.1007/s00394-018-1634-0. Epub 2018 Apr 25. Eur J Nutr. 2019. PMID: 29691654 Free PMC article.
Cited by
-
The Potential Role of Spa Therapy in Managing Frailty in Rheumatic Patients: A Scoping Review.Healthcare (Basel). 2023 Jun 30;11(13):1899. doi: 10.3390/healthcare11131899. Healthcare (Basel). 2023. PMID: 37444733 Free PMC article. Review.
-
The role of vitamin D in the link between physical frailty and cognitive function: A mediation analysis in community-dwelling Chinese older adults.Front Nutr. 2022 Jul 22;9:922673. doi: 10.3389/fnut.2022.922673. eCollection 2022. Front Nutr. 2022. PMID: 35958260 Free PMC article.
-
The effects of vitamin D supplementation on frailty in older adults at risk for falls.BMC Geriatr. 2022 Apr 10;22(1):312. doi: 10.1186/s12877-022-02888-w. BMC Geriatr. 2022. PMID: 35399053 Free PMC article. Clinical Trial.
-
Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-Health Trial.J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1428-1439. doi: 10.1002/jcsm.12759. Epub 2021 Aug 1. J Cachexia Sarcopenia Muscle. 2021. PMID: 34337905 Free PMC article. Clinical Trial.
-
Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency.Nutrients. 2021 Apr 10;13(4):1247. doi: 10.3390/nu13041247. Nutrients. 2021. PMID: 33920130 Free PMC article. Review.
References
-
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281. - PubMed
-
- Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. - PubMed
-
- Rockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004;59:1310–1317. - PubMed
-
- Cawthon PM, Marshall LM, Michael Y, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007;55:1216–1223. - PubMed
-
- Ensrud KE, Ewing SK, Taylor BC, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007;62:744–751. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- U01 AR045614-01/AR/NIAMS NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- U01 AR45583/AR/NIAMS NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
